Sort by
Keyphrases
Adenovirus Vaccine
100%
Ebola Virus
100%
Enhanced Protection
100%
Ebola Vaccine
100%
Lethal Challenge
60%
Immune Response
40%
Adenovirus
40%
Nonhuman Primate
40%
Exposure Therapy
40%
Full Protection
40%
ZEBOV
40%
Expression Cassette
40%
Infected Individual
20%
T Cell Response
20%
Guinea pig
20%
Vaccination
20%
Glycoprotein
20%
Death Rate
20%
B Cell Response
20%
Zaire Ebolavirus
20%
Complete Protection
20%
Phase I Clinical Trial
20%
Vesicular Stomatitis Virus
20%
Recombinant Adenovirus
20%
Improved Vaccines
20%
Antigen Expression
20%
Codon Optimization
20%
Molecular Components
20%
Ebola Infection
20%
Adenovirus Type 5
20%
Post-challenge
20%
Kozak Sequence
20%
Bodily Fluids
20%
Conditionally Replicating Adenovirus
20%
CMV Promoter
20%
Reconfiguration
20%
CAG Promoter
20%
Molecular Modification
20%
Previous Generation
20%
Medicine and Dentistry
Adenoviridae
100%
Ebolavirus
100%
Ebola Vaccine
83%
Immune Response
33%
Promoter Region
33%
Clinical Trial
16%
Mortality Rate
16%
Infection
16%
T Cell
16%
Glycoprotein
16%
B Cell
16%
Serotype
16%
Codon
16%
Vesiculovirus
16%
Recombinant
16%
Zaire Ebolavirus
16%
Exposure Therapy
16%
Treatment Exposure
16%
Immunology and Microbiology
Ebola Virus
100%
Adenoviridae
100%
Ebola Vaccine
83%
Immune Response
33%
Promoter Region
33%
T Cell
16%
Wild Type
16%
Guinea Pig
16%
Glycoprotein
16%
Mortality Rate
16%
Serotype
16%
B Cell
16%
Zaire Ebolavirus
16%
Vesiculovirus
16%
Codon
16%
Replication
16%
Infection
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ebola Virus
100%
Adenoviridae
100%
Ebola Vaccine
83%
Clinical Trial
16%
Infection
16%
Guinea Pig
16%
Glycoprotein
16%
Mortality Rate
16%
Recombinant
16%
Vesiculovirus
16%
Zaire Ebolavirus
16%
Molecular Modification
16%